US$ 29.79
foxo4-dri senolytic peptide 2024 study The disordered p53 transactivation domain is the target of FOXO4 and the compound FOXO4-DRI Peptide | Senolytic &
Description
Induction of Mucin and MUC5AC expression by the protease activity of Aspergillus fumigatus in airway epithelial cells

Mutagenicity of anthracycline glycosides and bleomycins in Salmonella assay system

Comparative Longevity Testing Models Researchers track the phenotypic shifts of cellular lines following exposure to the antagonist

Corrects deficiency-related fatigue and metabolic impairment
